Literature DB >> 17707347

Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls.

Catherine M Diaz-Asper1, Terry E Goldberg, Bhaskar S Kolachana, Richard E Straub, Michael F Egan, Daniel R Weinberger.   

Abstract

BACKGROUND: Catechol-O-methyltransferase (COMT) val(108/158)met (rs4680) is thought to affect dopamine regulated prefrontal cortical activity during working memory (WM) tasks, and to weakly increase risk for developing schizophrenia. Recently, other single nucleotide polymorphisms (SNPs) across the gene have emerged as additional risk factors for schizophrenia: namely rs737865, rs165599, and rs2097603. In a large sample, we examined whether these SNPs affect WM.
METHODS: Schizophrenic probands (n = 325), their nonpsychotic siblings (n = 359), and normal control subjects (n = 330) completed tests of WM function. Data were analyzed with a series of mixed model analyses of variance (ANOVAs).
RESULTS: Val homozygotes performed most poorly on all conditions of the n-back, irrespective of diagnosis. Additionally, there was a trend towards a disease-only val(108/158)met effect on a test of attentional set-shifting; val homozygote probands performed most poorly. Significant or near-significant effects of rs737865 were found on all conditions of the n-back, with G homozygotes performing worst. There also was a disease-only COMT rs737865 effect on the 0-back. None of the other SNPs showed main effects by themselves. A haplotype constructed from promoter and val(108/158)met SNPs showed main effects on WM parameters, consistent with inverted U models of dopamine signaling.
CONCLUSIONS: We extended earlier findings of a val(108/158)met effect on WM function, and suggest that combinations of alleles within COMT may modulate the val(108/158)met effect in a nonlinear manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707347      PMCID: PMC3708610          DOI: 10.1016/j.biopsych.2007.03.031

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  46 in total

1.  The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia.

Authors:  Raymond C K Chan; Ronald Y L Chen; Eric Y H Chen; Tomy C K Hui; Eric F C Cheung; H K Cheung; Pak Sham; Tao Li; David Collier
Journal:  J Int Neuropsychol Soc       Date:  2005-03       Impact factor: 2.892

2.  Tolcapone improves cognition and cortical information processing in normal human subjects.

Authors:  José A Apud; Venkata Mattay; Jingshan Chen; Bhaskar S Kolachana; Joseph H Callicott; Roberta Rasetti; Guilna Alce; Jennifer E Iudicello; Natkai Akbar; Michael F Egan; Terry E Goldberg; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2006-10-25       Impact factor: 7.853

Review 3.  Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.

Authors:  Jin-Bo Fan; Chang-Shun Zhang; Niu-Fan Gu; Xing-Wang Li; Wei-Wei Sun; Hong-Yan Wang; Guo-Yin Feng; David St Clair; Lin He
Journal:  Biol Psychiatry       Date:  2005-01-15       Impact factor: 13.382

4.  Impact of complex genetic variation in COMT on human brain function.

Authors:  A Meyer-Lindenberg; T Nichols; J H Callicott; J Ding; B Kolachana; J Buckholtz; V S Mattay; M Egan; D R Weinberger
Journal:  Mol Psychiatry       Date:  2006-06-20       Impact factor: 15.992

5.  Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.

Authors:  B-C Ho; T H Wassink; D S O'Leary; V C Sheffield; N C Andreasen
Journal:  Mol Psychiatry       Date:  2005-03       Impact factor: 15.992

6.  Effect of catechol-O-methyltransferase val158met genotype on attentional control.

Authors:  Giuseppe Blasi; Venkata S Mattay; Alessandro Bertolino; Brita Elvevåg; Joseph H Callicott; Saumitra Das; Bhaskar S Kolachana; Michael F Egan; Terry E Goldberg; Daniel R Weinberger
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

7.  Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.

Authors:  Andreas Meyer-Lindenberg; Philip D Kohn; Bhaskar Kolachana; Shane Kippenhan; Aideen McInerney-Leo; Robert Nussbaum; Daniel R Weinberger; Karen Faith Berman
Journal:  Nat Neurosci       Date:  2005-04-10       Impact factor: 24.884

Review 8.  Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.

Authors:  Elizabeth M Tunbridge; Paul J Harrison; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-02-14       Impact factor: 13.382

9.  Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: impact of distractors.

Authors:  Sandra Jazbec; Christos Pantelis; Trevor Robbins; Thomas Weickert; Daniel R Weinberger; Terry E Goldberg
Journal:  Schizophr Res       Date:  2006-10-19       Impact factor: 4.939

Review 10.  The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons.

Authors:  N Craddock; M J Owen; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2006-05       Impact factor: 15.992

View more
  54 in total

1.  A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes.

Authors:  Krista M Wisner; Brita Elvevåg; James M Gold; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2010-10-28       Impact factor: 4.939

Review 2.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

3.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

4.  Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype?

Authors:  Alan E Ceaser; Terry E Goldberg; Michael F Egan; Robert P McMahon; Daniel R Weinberger; James M Gold
Journal:  Biol Psychiatry       Date:  2008-07-02       Impact factor: 13.382

5.  The "Warrior" COMT Val/Met Genotype Occurs in Greater Frequencies in Mixed Martial Arts Fighters Relative to Controls.

Authors:  Jaime L Tartar; Dominick Cabrera; Sarah Knafo; Julius D Thomas; Jose Antonio; Corey A Peacock
Journal:  J Sports Sci Med       Date:  2020-02-24       Impact factor: 2.988

Review 6.  COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.

Authors:  Elisa Ira; Martina Zanoni; Mirella Ruggeri; Paola Dazzan; Sarah Tosato
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

7.  COMT genotype affects prefrontal white matter pathways in children and adolescents.

Authors:  Moriah E Thomason; Robert F Dougherty; Natalie L Colich; Lee M Perry; Elena I Rykhlevskaia; Hugo M Louro; Joachim F Hallmayer; Christian E Waugh; Roland Bammer; Gary H Glover; Ian H Gotlib
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

8.  Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex.

Authors:  C C Lapish; S Ahn; L M Evangelista; K So; J K Seamans; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2008-10-15       Impact factor: 4.530

Review 9.  Genes, cognition and brain through a COMT lens.

Authors:  D Dickinson; B Elvevåg
Journal:  Neuroscience       Date:  2009-05-13       Impact factor: 3.590

10.  Neuroimaging in psychiatry: from bench to bedside.

Authors:  David E J Linden; Andreas J Fallgatter
Journal:  Front Hum Neurosci       Date:  2009-12-23       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.